About Us
Submissions
Advertising
SIGN IN
|
SUBSCRIBE
ISSUE
CURRENT
ARCHIVE
SUPPLEMENTS
JADPRO LIVE
2020
JADPRO Live 2019 Activities
JADPRO Live 2018 Activities
CE
RESOURCES
Myelofibrosis: Narratives on Collaboration
NSCLC
HDMTX-Induced AKI
Relapsed/Refractory Multiple Myeloma
Management of irAEs
Managing Classical Hodgkin Lymphoma
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
APSHO EMPOWERED
CAREER CENTER
Narratives: HER2-Positive Breast Cancer
QUICK TIPS
HIGHLIGHTS
PODCAST
Learn more on this topic:
Defining the New Treatment Paradigm for Patients with Chronic Lymphocytic Leukemia
What do the NCCN Guidelines recommend for diagnostic workup and risk assessment in patients with newly diagnosed CLL?
Jeffrey Jones, MD, MPH
The James Cancer Hospital at The Ohio State University
Related Material
How do I manage infusion reactions?
What is the best way to monitor CLL patients?
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our
Privacy Policy
to learn more.
